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Curcumin has been reported can interact with multiple molecular 
targets involved in a large variety of diseases. Accumulated evidence 
indicated curcumin plays an inhibitory role against infection of numerous 
viruses. Some studies have been reported that curcumin can interfere the 
infection processes of dengue virus. In this work, a benzenesulfonyl curcumin, 
(3E,5E)-3,5-bis(4-methoxybenzylidene)-1-(phenylsulfonyl) piperidin-4-one 
(compound 2) has been synthesized by two steps of reactions. The structure 
of compound 2 has been established based on the interpretation of spectral 
data include UV, FT-IR, MS/MS, 1H and 13C NMR. Then, the in silico studies 
have been also performed to predict the potency of compound 2 as inhibitor 
for dengue virus Type 2 (DEN 2) NS2B/NS3 protease. The in silico studies 
showed that compound 2 has hydrogen bonding with His51 residue, and 
amazingly that the other catalytic triad such as Asp75 and Ser135 were also 
showed interactions with the ligand. It is presumably that this compound 
showed very good activity against DEN2 and can be developed as a new 
inhibitor for dengue viruses. 
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INTRODUCTION  
Dengue is the most rapidly spreading disease 
caused by a mosquito-borne virus in the word. It is 
a serious re-emerging infection disease that is 
endemic in over 100 countries (Morens & Fauci, 
2008). The World Health Organization (WHO) has 
considered dengue as a major global public health 
challenge in the tropic and subtropic nations. 
Between 1960 and 2010, dengue has seen a 30-fold 
upsurge worldwide, due to the increase of 
population growth rate, global warming, unplanned 
urbanization, inefficient mosquito control, frequent 
air travel, and lack of health care facilities (Guzman 
et al., 2010).  
There are four serotypes of dengue virus 
(DEN1, DEN2, DEN3 and DEN4), with dengue virus 
type 2 (DEN2) being the most prevalent (Frimayanti 
et al., 2011). A number of studies have already 
revealed that the non-structural 3 (NS3) serine 
protease is required for the maturation of the viral 
polyprotein. The binding of the NS3 serine protease 
to an NS2B cofactor will form NS2B-NS3 protease 
complex (Chambers et al., 1993) which is required 
to cleave the viral precursor proteins that is 
required for DEN2 viral replication (Falgout et al., 
1991). Thus, it is a promising target for the 
development of dengue antiviral drugs (Sampath 
and Padmanabhan, 2009). There are two potential  
targets for dengue virus NS2B/NS3 protease. First, 
by targeting the active site of protease and the second 
is by blocking the association of NS3 protease with 
its protein cofactor NS2B (Power and Setzer, 2016). 
Curcumin has been reported can interact 
with multiple molecular targets involved in a large 
variety of diseases (Kumar et al., 2017). 
Accumulated evidence indicated curcumin plays an 
inhibitory role against infection of numerous 
viruses (Mathew & Hsu, 2018). Some studies have 
been reported that curcumin can disrupt the 
infection processes of dengue virus (Padilla-S et al., 
2014). In this work, we reported the synthesis of a 
benzenesulfonyl curcumin analogue (compound 2) 
under reflux. Then, the molecular docking study 
and molecular dynamic (MD) simulation were also 
performed to predict the potency of compound 2 as 
inhibitor for dengue virus NS2B/NS3 protease. 
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MATERIAL AND METHODS 
The materials were used in this work are 
mentioned as follow 4-piperidone, 4-methoxy-
benzaldehyde, benzenesulfonyl chloride, sodium 
hydroxide, cesium carbonate and some organic 
solvents, such as ethanol, acetonitrile, n-hexane and 
methanol were produced by Merck or Sigma-
Aldrich. Melting point was determined on a Fisher-
Johns apparatus (Fisher Scientific, Waltham, MA, 
USA) (uncorr). TLC Analysis was carried out using 
GF254 (Merck Millipore, Darmstadt, Germany)  
under UV Lamp 254/366nm (Camag TM, Camag 
Chemie-Erzeugnisse and Adsorptionstechnik                   
AG, Muttenz, Switzerland). UV spectrum was 
recorded on GenesysTM 10S UV-Visible 
spectrophotometer (Thermo Scientific TM, Waltham, 
MA, USA). FT-IR spectrum was recorded in KBr 
powder on a Shimadzu FT-IR Prestige-21 
spectrophotometer (Shimadzu  Corporation, Kyoto,  
Japan). Mass  spectrum was recorded on LC-MS/MS 
+ESI (Agilent Technologies 6550 iFunnel Q-TOF 
LC/MS). 1H and 13C-NMR spectral data were 
recorded on an Agilent (Agilent Technologies, 
Santa Clara, CA, USA) at 500 MHz and 125 MHz, 
respectively.  
 
Synthesis of (3E,5E)-3,5-bis(4-methoxy benzyli-
dene)piperidin-4-one (1) 
The synthesis of compound 1 has been 
carried out by modifying the previous method 
(Eryanti et al., 2014). 4-piperidone (5mmol) and 4-
methoxybenzaldehyde (10mmol) were dissolved in 
absolute ethanol (20mL). The KOH solution (10%, 
10mL) was added drop by drop into the solution. 
Then, the mixture was refluxed at 80ᵒC. The 
reaction was monitored every 30min by TLC. After 
the reaction was completed, the mixture was cooled 
in ice bath and the precipitate was filtered in vacuo, 
washed by aqua DM and n-hexane and dried in a 
desiccator. Then, the solid crude product was 
recrystallized in methanol to afford pure compound 
1. 
 
Synthesis of (3E,5E)-3,5-bis(4-methoxybenzy-
lidene)-1-(phenyl sulfonyl)piperidin-4-one 
(2) 
Compound 1 (1mmol) and cesium carbonate 
(1.5mmol) were dissolved in acetonitrile (20mL). 
Benzenesulfonyl chloride (1mmol) was added drop 
by drop into the solution. Then, the mixture was 
refluxed at 80ᵒC for 12h. The reaction was 
monitored every 2h by TLC. After the reaction was 
completed, the solvent was evaporated by vacuum 
rotary evaporator. Then, the solid was dissolved in 
water and extracted with ethyl acetate (1:1). The 
ethyl acetate layer was collected and the solvent 
was evaporated by vacuum rotary evaporator to 
afford the solid crude product. The crude product 
was washed by NaHCO3 and aqua DM and 
recrystallized in methanol to afford a pure 
compound 2. 
Compound 2 was obtained as a yellow solid 
in 88 % yield. The melting point was recorded at 
210-212°C (uncorr). The HPLC chromatogram 
showed a single peak at tR = 17.4min. The UV 
spectra in EtOH showed λmax (nm) at 243 and 365. 
The FT-IR spectra in KBr powder showed the 
absorption bands (cm−1) at 3078, 3000, 2907, 2838, 
1674, 1599, 1508, 1444, 1351, 1171, 700. The mass 
of 2 in MS/MS spectra (+ESI) was found as [M+H+] 
(C27H26NO5S) at m/z = 476.1543 and 476.1515. The 
1H NMR spectra was recorded in DMSO-d6 
(500MHz): 7.68 (t, 1H, J = 6.5 Hz), 7.54-7.56 (m, 4H), 
7.50 (s, 2H), 7.45 (d, 4H, J= 8.2 Hz), 7.09 (d, 4H, J= 
8.1 Hz), 4.61 (s, 4H), 3.84 (s, 6H). The 13C NMR 
spectra was recorded in DMSO-d6 (125 MHz): 
184.27, 160.92, 137.83, 137.26, 133.93, 132.99, 
129.84, 128.86, 127.61, 127.09, 114.99, 55.85, 
47.25.  
 
Molecular docking study and molecular dynamic 
simulation 
The initial structure of the ligand is needed 
to obtain, it were optimized using density 
functional theory (DFT) at the B3LYP/6-311G level 
using Gaussian 09 software package. Docking of 
compound 2 was performed using Autodock 
software package (Jasril et al., 2017). Protein was 
downloaded from protein database with PDB ID: 
2FOM. The rigid protein and flexible ligand was 
prepared using Autodock tools 1.5.6. software 
package. The polar and nonpolar hydrogen atom 
were then individually added and merged to the 
protein structure. Kollman charges and solvation 
parameters were determined. Gasteiger charges 
were added to the minimized ligand structures, and 
all bonds were made rotatable and flexible by 
allowing the detection of root torsion. A grid box of 
the protein structure was then generated using 
Autogrid 4 software with default atom types 
(carbon, hydrogen, oxygen and nitrogen), grid 
spacing of 0.41 Å, dimensions of 126 × 126 × 126 
points along the x, y and z axes and centered on the 
protein for the docking. Molecular dynamic 
simulation was performed for compound 2 and 
panduratin A was used as positive control 
(Frimayanti, et al., 2011) using the program NAMD 
(NAnoscale Molecular Dynamics program; v 2.9) 
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(Nelson et al., 1996), and all files were generated 
using visual MDs (VMD) (Humphrey et al., 1996). 
The protein was solvated with a TIP3P water box 
with a 2.5 Å layer of water for each direction of the 
coordinate structure, and a CHARMM Chemistry at 
HARvard Macromolecular Mechanics) was used as 
a force field. Generaly, the ligands was remained 
stably in the binding pocket through out 100ps MD 
simulation. The MD simulation was running with 
the following parameters, the time step of 
10femtosec/step, dcdfreq of 1000 steps/trajectory 
snapshot and with total 1000 run step. The MD was 
performed until the simulation reach the  
equilibrium or steady state.  
 
RESULT AND DISCUSSION 
The synthesis of compound 2 was 
conducted under reflux by two steps of reaction. 
The first step is synthesis of curcumin analogue 
via Claisen-Schmidt condensation and the 
second step is synthesis of synthesis of 
benzenesulfonyl curcumin via nucleophilic 
substitution (Figure 1).  
The UV spectra of compound 2 was recorded 
in ethanol and showed the max (nm) at 243 and 
365. The absorptions indicated the presence of 
conjugated of double bonds in the aromatic rings of 
compound 2. The FT-IR spectra showed the 
absorption bands (cm-1) at 3078, 3000, and 1599. 
These three absorptions respectively were due to 
the presence of asymmetrical C-H, symmetrical C-H 
and C=C vibration in the aromatic phenyl rings of 
compound 2. The absorption bands at 2907, 2838 
and 1171 respectively were due to the presence of 
asymmetrical C-H vibration, symmetrical C-H 
vibration and C-O vibration in both methoxy 
groups. The absorption band at 1674 indicated the 
presence of the conjugated carbonyl group and the 
absorption bands at 1444 and 1351 were due to the 
presence of S=O vibration in sulfonyl group. In 
addition, the MS/MS spectra also showed the 
appropriate mass for 2. 
The 1H and 13C NMR spectra (Figure 2 and 3) 
also showed the appropriate chemical environment 
for protons and carbons of compound 2. The 1H 
NMR spectra showed a singlet signal (6H) at δ 
(ppm) 3.84. This signal was due to the presence of 
the aliphatic protons in two methoxy groups. 
Another aliphatic proton signal (4H) was appeared 
at δ 4.61. This signal was due to the presence of the 
methylene protons in the heterocyclic ring of 
piperidin-4-one. The aromatic proton signals of 
three phenyl ring were appeared at δ 7.68-7.09.            
The triplet signal at δ 7.68 and multiplet signals at δ 
7.54-7.56 were due to the presence of the aromatic 
protons in benzenesulfonyl moiety, whereas two 
doublet signals at δ 7.45 (4H) and 7.09 (4H) were 
due to the presence of the aromatic protons in            
both p-methoxyphenyl rings. The singlet signal 
(2H) at δ 7.50 was due to the presence of β protons 
in the unsaturated , β carbonyl system of 
compound 2.  
The 13C NMR spectra showed aliphatic 
carbon signals at  55.85 and 47.25. These two 
signals due to the two carbons in two methoxy 
groups and two carbons in heterocyclic ring of 
piperidin-4-one, respectively. The signal at δ 
184.27 was due to the presence of carbon in the 
carbonyl group and the signal at δ 160.92 was due 
to the presence of an oxy-aryl carbon. Then, the 
signals at δ 137.83-114.99 were due to the presence 
of aromatic carbons in a benzenesulfonyl and two 
4-methoxyphenyl rings of compound 2. 
The  Gaussian calculation is come out with 
the geometry for energy optimization values for the 
ligand is 1358 Ha. Base on this calculation, it seem 
that it is supported with our hyphothesis  that the 
(E) configuration is more stable than (Z) 
configuration. 
The molecular docking study was performed 
to predict the potency of compound 2 as inhibitor 
for dengue virus NS2B/NS3 protease. Based on 
docking results, it seem that compound 2 is active 
against DEN2 NS2B/NS3. Hydrogen bonding was 
performed between ligand and one of the catalytic 
triad (i.e. His51) (Table I). van der Waals 
interaction was also established between ligand 
and Gly151 and π interaction with the residue 
Pro132 (Table I). In addition, this compound also 
has hydrophobic interaction with Arg54 (Table I). 
The spatial arrangement of the compound 2 is 
depicted in (Figure 4) and panduratin A was used 
as positive control. it has been docked previously 
(Frimayanti et al., 2011).  
 
MD simulation was also performed to 
panduratin A as a positive control and compound 2. 
The interaction between ligand and receptor               
is still maintain to have hydrogen bonding                   
with His51 residue, and amazingly that the                   
other catalytic triad such as Asp75 and Ser135 were 
also showed interactions with the ligand. MD 
simulation is carried out on this ligand to                      
further explore the interaction between ligand and 
receptor (Adam et al., 2015). The properties of this 
complex was inspected to check the stability of MD. 
In this study, the MD simulations were performed 
at temperature of 300ᵒK to  check  the  affinity  of 
the ligand to the binding site.  
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Figure 1. Synthesis of compound 2 under reflux, (i) KOH, EtOH, (ii) PhSO2Cl, Cs2CO3, CH3CN. 
 
 
 
Figure 2.  1H NMR spectra of compound 2 
 
 
 
 
Figure 3. 13C NMR spectra of compound 2 
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Table I. Docking output 
 
Compounds 
Interactions 
van der Waals Hydrophobic π-Interaction Hydrogen Bonding 
Panduratin A His51; Pro132 - - His51; Gly153 
Compound 2 Gly51 Arg54 Pro132 His51 
 
 
 
Figure 4. Spatial arrangement of the compound 2 
 
 
 
 
Figure 5. Visualization of MD simulation of compound 2 
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Generally, this ligand are maintaned to binding with 
the active site and essential residues such as His51, 
Asp75, Ser135, Pro132 and Gly151 (Frimayanti et 
al., 2011).  
 
Table II. The binding free energy from the MD 
simulation 
 
Compounds 
Binding free energy 
(kcal/mol) 
Panduratin A -59.78 
Compound 2 -61.01 
 
The MD simulation results are shown that the 
range of binding free energy betwen ligand and 
panduratin A was not too large (Table II). After the 
MD simulation, the ligand was maintained to 
interact with the same residues (Figure 5)., it is 
presumably that compound 2 showed very good 
activity against DEN2 NS2B/NS3 and can be 
developed as a new inhibitor for dengue. 
 
CONCLUSION 
A benzenesulfonyl curcumin analogue has 
been synthesized via two steps reaction. All the 
spectroscopic data agreed with the structure of 
product that was expected. The in silico studies 
showed that compound 2 was able to maintain the 
hydrogen bonding with the active site residue such 
as His51, Asp75 and Ser135, in addition, this 
compound also has the range of the binding free 
energy is so close with the panduratin A (i.e. 
positive control). It is presumably that this 
compound showed very good activity against DEN2 
and can be developed as a new inhibitor for dengue 
DEN2 NS2B/NS3. 
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